Sandra Silva
Papers
1
Total Citations
83
H-Index
1
About
Sandra Silva is a leading researcher in molecular epidemiology, with a primary focus on human papillomavirus (HPV) detection and cervical cancer prevention. Her most-cited work, "Comparison of Two PCR-Based Human Papillomavirus Genotyping Methods" (2008, 83 citations), established critical methodological standards for HPV genotyping. By rigorously comparing two consensus primer PCR methods using cervical specimens from the landmark NCI/Costa Rica HPV16/18 vaccine trial, Silva provided essential validation for accurate detection of individual and carcinogenic HPV genotypes. This foundational contribution has shaped how researchers and clinicians assess HPV infection and vaccine efficacy, directly impacting global cervical cancer screening strategies. Silva’s work bridges molecular diagnostics and public health, enabling more precise risk stratification for HPV-related disease. Her research continues to influence the design of large-scale epidemiological studies and vaccine impact assessments, making her a key figure in the fight against cervical cancer.
Research Focus
Key Achievements
Top Papers
- 1Comparison of Two PCR-Based Human Papillomavirus Genotyping Methods83 citations · 2008